Pancreatic neuroendocrine tumors: Our approach

Hepato-Gastroenterology

Volumn 55, Issue 81, 2008, Pages 275-281

  Jagad, Rajan B ^a   Koshariya, Mahim ^a   Kawamoto, Jun ^a   Papastratis, P ^a   Kefalourous, H ^a   Patris, V ^a   Porfiris, T ^a   Gevrielidis, Pascailis ^a   Tzouma, Christina ^a   Lygidakis, N J ^a,b  

^a ATHENS MEDICAL CENTER   (Greece)

^b NONE   (Greece)

Author keywords

Aggressive surgery; Pancreatic neuroendocrine tumors

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; DATA ANALYSIS; DEMOGRAPHY; FEMALE; GASTRINOMA; GLUCAGONOMA; HUMAN; INSULINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; PANCREAS CARCINOMA; PANCREAS ISLET CELL TUMOR; PANCREAS TUMOR; PANCREATICODUODENECTOMY; POSTOPERATIVE CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; CARCINOMA, NEUROENDOCRINE; ENDOSONOGRAPHY; FEMALE; HEPATECTOMY; HUMANS; INDIUM RADIOISOTOPES; LIVER NEOPLASMS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SOMATOSTATIN; TOMOGRAPHY, X-RAY COMPUTED;

EID: 41549141286     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (82)

1. Matthews BD, Smith TI, Kercher KW, Holder WD Jr, Heniford BT: Surgical experience with functioning pancreatic neuroendocrine tumors. Am Surg 2002; 68:660-666.
2. Pearl J, Elster E, Golocovsky M: Nonfunctioning islet cell carcinoma of the pancreas: case report. Am Surg 2002; 68:886-888.
3. Lozano-Salazar RR, Herrera MF, Hernandez-Ortiz J, Campuzano M: Endocrine tumors of the pancreas. Rev Gastroenterol Mex 1997; 62:212-217. (In Spanish with English abstract)
4. Wilder RM, Allan FN, Power MH, Robertson HZE: Carcinoma of islands of pancreas, hyperinsulinism and hypoglycemia. JAMA 1927; 89:348.
5. Jensen RT, Norton JA: Endocrine neoplasms of the pancreas. In: Yamada T (Ed.). Textbook of Gastroenterology. Vol 2. 2nd Edition. Philadelphia, Pa: JB Lippincott, 2003; pp. 2108-2146.
6. Closset J, Delhaye M, Sperduto N, et al: Nonfunctioning neuroendocrine tumors of the pancreas: clinical presentation of 7 patients. Hepatogastroenterology 1996; 43(12):1640-1644.
7. Nikou GC, Toubanakis C, Nikolaou P, et al: VIPomas: an update in diagnosis and management in a series of 11 patients. Hepatogastroenterology 2005; 52(64):1259-1265.
8. Yeh CN, Chen MF, Chen TC: Surgical treatment of pancreatic vasoactive intestinal polypeptide-secreting tumor: a case report. Hepatogastroenterology 2001; 48(38):421-423.
9. Service FJ, McMahon MM, O'Brien PC, Ballard DJ: Functioning insulinoma - incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 1991; 66:711-719.
10. Jensen, R: Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type 1. J Intern Med 1998; 243:477-488.
11. Ince AT, Ovünç O, Celikel CA, et al: Cyclooxygenase-2 Expression in Gastroenteropancreatic Neuroendocrine Tumors. Hepatogastroenterology 2007; 54:1125-1129.
12. Eriksson B, Arnberg H, Lindgren PG, Lorelius LE, Magnussen A, Lundqvist G, et al: Neuroendocrine pancreatic tumours: clinical presentation, biochemical and histopathological findings in 84 patients. J Intern Med 1990; 228:103-113.
13. Ziad S El Rassi, Raouf M Mohsine, Francoise Berger, et al: Endocrine Tumors of the Extrahepatic Bile Ducts. Pathological and Clinical Aspects, Surgical Management and Outcome. Hepatogastroenterology 2004; 51:1295-1300.
14. Sohn TA, Yeo CF, Cameron JL, et al: Resected adenocarcinoma of the pancreas- 616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 2000; 4:567-579.
15. Chu QD, Hill HC, Douglass HO, et al: Predictive factors associated with longterm survival in patients with neuroendocrine tumors of the pancreas. Ann Surg Oncol 2002; 9:855-862.
16. Evans DB, Skibber JM, Lee JE, et al: Nonfunctioning islet cell carcinoma of the pancreas. Surgery 1993; 114:1175-1182.
17. Dralle H, Krohn SL, Karges W, Boehm BO, Brauckhoff M, Gimm O: Surgery of resectable nonfunctioning neuroendocrine pancreatic tumors. World J Surg 2004; 28:1248-1260.
18. Phan GQ, Yeo CJ, Hruban RH, Lillemoe KD, Pitt HA, Cameron JL: Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients. J Gastrointest Surg 1998; 2:472-482.
19. Varas MJ: Tumores endocrinos pancreaticus. En: Pajares JM (Ed.). Temas actuales en Aparato Digestivo 2. Tomo II. Barcelona: Dispharm S.A., 1994; pp. 557-576.
20. Kwekkeboom DJ, Krenning EP, Bakker WH, Oei HY, Kooij PPM, Lamberts SWJ: Somatostatin analogue scintigraphy in carcinoid tumors. Eur J Nucl Med 1993; 20:283-292.
21. Nikou GC, Lygidakis NJ, Toubanakis C, Pavlatos S, et al: Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues. Hepatogastroenterology 2005; 52(63):731-741.
22. Anderson MA, Carpenter S, Thompson NW, Nostrant TT, Elta GH, Scheiman JM: Endoscopic ultrasound is highly accurate and directs managements in patients with neuroendocrine tumors of the pancreas. Am J Gastroenterol 2000; 95(9):2271-2277.
23. Varas Lorenzo MJ, Miquel Collell JM, Maluenda Colomer MD, Boix Valverde J, Armengol Miró JR: Preoperative detection of gastrointestinal neuroendocrine tumors using endoscopic Ultrasonography. REV ESP ENFERM DIG (Madrid) 2006; 98(11):828-836.
24. Shibata C, Funayama Y, Fukushima K, et al: Role of selective arterial secretin injection test in treatment of gastrinoma. Hepatogastroenterology 2006; 53(72):960-963.
25. Capella C, Heitz PU, Höfler H, Solcia E, Klöppel G: Revised classification of neuroendocrine tumors of the lung, pancreas and gut. Virchows Arch 1995; 425:547-560.
26. Maurer CA, Baer H-U, Dyong TH, Mueller-Garamvoelgyi E, Friess H, Ruchti C, Reubi JC, Büchler MW: Carcinoid of the pancreas: Clinical characteristics and morphological features. Eur J Cancer 1996; 32A:1109-1116.
27. Fendrich V, Bartsch DK, Langer P, et al: Diagnosis and surgical treatment of insulinoma: experiences in 40 cases. Dtsch Med Wochenschr 2004; 129:941-946.
28. Norton JA: Surgery and prognosis of duodenal gastrinoma as a duodenal neuroendocrine tumor. Best Pract Res Clin Gastroenterol 2005; 19:699-704.
29. Bartsch DK, Schilling T, Ramaswamy A, et al: Management of non-functioning islet cell carcinomas. World J Surg 2000; 24:1418-1424.
30. Dralle H, Krohn SL, Karges W, et al: Surgery of resectable non-functioning neuroendocrine pancreatic tumors. World J Surg 2004; 28:1248-1260.
31. García-Sancho Téllez L, Rodriguez Montes JA, Burgos Lizaldez E, García-Sancho Martin L: Pancreatic Neuroendocrine Tumors. Report of Nine Cases. Hepatogastroenterology 2000; 47:1458-1461.
32. Phan GQ, Yeo CJ, Cameron JL, Maher MM, Hruban RH, Udelsmann R: Pancreaticoduodenectomy for selected periampullary neuroendocrine tumors: Fifty patients. Surgery 1997; 122:989-997.
33. Höfler H, Stier A, Schusdziarra V, Siewert JR: Klassifikation der neuroendocrinen Tumoren des Gastrointestinaltrakts und des Pancreas und ihre therapeutische Relevanz. Chirurg 1997; 68:107-115.
34. Correnti S, Liverani A, Antonini G, et al: Intraoperative ultrasonography for pancreatic insulinomas. Hepatogastroenterology 1996; 43(7):207-211.
35. Kalafat H, Mihmanli I, Saribeyoglu K, Belli A: Intraoperative doppler ultrasound: a reliable diagnostic method in insulinoma. Hepatogastroenterology 2007; 54(76):1256-1218.
36. Kaneko T, Nakao A, Inoue S, et al: Intraportal endovascular ultrasonography as a new diagnostic 5 procedure in pancreatic surgery. Hepatogastroenterology 1995; 42(5):711-716.
37. Kaneko T, Inoue S, Sugimoto H, et al: Intraoperative diagnosis of pancreatic cancer extension using IVUS. Hepatogastroenterology 2001; 48(40):944-948.
38. Jain S, Sacchi M, Vrachnos P, Lygidakis NJ: Carcinoma of the pancreas with portal vein involvement - our experience with a modified technique of resection. Hepatogastroenterology 2005; 52(65):1596-600.
39. Lygidakis NJ: Regional vascular resection for pancreatic head carcinoma. Hepatogastroenterology 1996; 43(11):1327-1333.
40. Lygidakis NJ, Jain S, Sacchi M, Vrachnos P: Reappraisal of a method of reconstruction after pancreatoduodenectomy. Hepatogastroenterology 2005; 52(64):1077-1082.
41. Lygidakis NJ: Reconstruction of alimentary continuity after subtotal duodenopancreatectomy. Hepatogastroenterology 1996; 43(10):971-979.
42. Lygidakis NJ, Savanis G, Touloupakis T, Pavlis T, Pothoulakis I: Technical considerations and results of a "new" method of reconstruction of alimentary continuity after duodenopancreatectomy. Hepatogastroenterology 1993; 40(5):448-451.
43. Lygidakis NJ, Dedematin G, Spenzaris N, et al: Pancreatic surgery today. Hepatogastroenterology 1996; 43(9):779-784.
44. Lygidakis NJ, Allema JH, van der Heyde MN, Tytgat GN, Tytgat KM: Reconstruction after subtotal duodenopancreatectomy in patients with pancreatic duct, distal bile duct and ampullary carcinoma: further experience with a personal technique. Hepatogastroenterology 1989; 36(6):486-489.
45. Miyagawa S, Makuuchi M, Lygidakis NJ, Noguchi T, Nishimaki K, Hashikura Y, Harada H, Hayashi K, Kakazu T, Pothoulakis J, Maganas D, Papadimitriou A: A retrospective comparative study of reconstructive methods following pancreaticoduodenectomy-pancreaticojejunostomy vs. pancreaticogastrostomy Hepatogastroenterology 1992; 39(5): 381-384.
46. Suzuki H, Kuwano H, Masuda N, Tuboi K, et al: Carcinoid of the Papilla of Vater; A Case Report. Hepatogastroenterology 2003; 50:371-373.
47. Tang CN, Tsui KK, Ha JPY, Wong DCT, Li MKW: Laparoscopic Distal Pancreatectomy: A Comparative Study. Hepatogastroenterology 2007; 54:265-271.
48. Kazanjian KK, Reber HA, Hines OJ: Resection of pancreatic neuroendocrine tumors: Results of 70 cases. Arch Surg 2006; 141:765-770.
49. Ammori BJ, El-Dhuwaib Y, Ballester P, Augustine T: Laparoscopic distal pancreatectomy for neuroendocrine tumors of the pancreas. Hepatogastroenterology 2005; 52:620-624.
50. Mabrut JY, Boulez J, Peix JL, et al: Laparoscopic pancreatic resection: a preliminary experience of 15 patients. Hepatogastroenterology 2005; 52(61):230-232.
51. Kang CM, Kim HG, Kim KS, et al: Laparoscopic distal pancreatectomy for solid pseudopapillary neoplasm of the pancreas-report of two cases. Hepatogastroenterology 2007; 54(76): 1053-1056.
52. Hellman P, Andersson M, Rastad J, et al: Surgical strategy for large or malignant endocrine pancreatic tumors. World J Surg 2000; 24:1353-1360.
53. Kouvaraki MA, Solorzano CC, Shapiro SE, et al: Surgical treatment of non-functioning pancreatic islet cell tumors. J Surg Oncol 2005; 89:170-185.
54. Sato T, Konishi K, Kimura H, et al: Strategy for pancreatic endocrine tumors. Hepatogastroenterology 2000; 47:537-539.
55. Norton JA, Kivlen M, Li M, et al: Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors. Arch Surg 2003; 138:859-866.
56. Lygidakis NJ, Bhagat AD, Vrachnos P, Grigorakos L: Multiorgan resection for advanced abdominal malignancies - is it feasible? Hepatogastroenterology 2007; 54(77):1353-1358.
57. Takada T, Yasuda H, Amano H, Yoshida M, Uchida T: Simultaneous hepatic resection with pancreato-duodenoectomy for metastatic pancreatic head carcinoma: Does it improve survival? Hepatogastroenterology 1997; 44:567-573.
58. Que FG, Nagorney DM, Batts KP, Linz LJ, Kvols LK: Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg 1995; 169:36-42.
59. Touzios JG, Kiely JM, Pitt SC, et al: Neuroendocrine hepatic metastases: Does aggressive management improve survival? Ann Surg 2005; 241:776-785.
60. Que FG, Nagorny DM, Batts KP, et al: Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg 1995; 169:36-42.
61. Sarmiento JM, Heywood G, Rubin J, et al: Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg 2003; 197:29-37.
62. Nave H, Mossinger E, Feist H, et al: Surgery as primary treatment in patients with liver metastases from carcinoid tumors: a retrospective, unicentric study over 13 years. Surgery 2001; 129:170-175.
63. Grazi GL, Cescon M, Pierangeli F, et al: Highly aggressive policy of hepatic resections for neuroendocrine liver metastases. Hepatogastroenterology 2000; 47(32):481-486.
64. Lygidakis NJ, Vlachos L, Raptis S, Rassidakis G, et al: New frontiers in liver surgery. Two-stage liver surgery for the management of advanced metastatic liver disease. Hepatogastroenterology 1999; 46(28):2216-2228.
65. Lygidakis NJ: Unresectable metastatic liver disease: new therapeutical alternatives. Hepatogastroenterology 1999; 46(Suppl 1):1297-1305.
66. Lygidakis NJ, Spentzouris N, Dedemadi G: Resectional liver surgery in metastatic liver disease. Hepatogastroenterology 1998; 45(22):1034-1038.
67. Lygidakis NJ, Thodorakopoulou M, Dedemadi G, Spenzouris N, et al: Resection of unresectable secondary liver tumors-new frontiers in liver surgery. Hepatogastroenterology 1997; 44(18):1632-1640.
68. Lygidakis NJ, Pearl A: Metastatic liver disease - a review. Hepatogastroenterology 1997; 44(17):1484-1487.
69. Lygidakis NJ, Savanis G, Pothoulakis J, Kapetanakis A: Transarterial locoregional immunostimulation and chemotherapy in patients with unresectable secondary liver tumours. Anticancer Res 1994; 14(2B):643-646.
70. Lygidakis NJ, Bhagat AD, Vrachnos P, Grigorakos L: Challenges in everyday surgical practice: synchronous bilobar hepatic colorectal metastases-newer multimodality approach. Hepatogastroenterology 2007; 54(76):1020-1024.
71. Grazi GL, Cescon M, Pierangeli F, et al: Highly aggressive policy of hepatic resections for neuroendocrine liver metastases. Hepatogastroenterology 2000; 47:481-486.
72. El Rassi ZS, Ferdinand L, Mohsine RM, et al: Primary and secondary liver endocrine tumors: clinical presentation, surgical approach and outcome. Hepatogastroenterology 2002; 49:1340-1346.
73. Gunji N, Miyamoto H, Orii K, et al: Pancreatic carcinoid: Transcatheter arterial chemoembolization of liver metastases. Hepatogastroenterology 2003; 50:2166-2168.
74. Cerwenka H, Raith J, Bacher H, Werkgartner G, et al: Is intraoperative ultrasonography during partial hepatectomy still necessary in the age of magnetic resonance imaging? Hepatogastroenterology 2003; 50(53):1539-1541.
75. Torzilli G, Leoni P, Gendarini A, Calliada F, et al: Ultrasound-guided liver resections for hepatocellular carcinoma. Hepatogastroenterology 2002; 49(43):21-27.
76. Herman K: Intraoperative ultrasound in gastrointestinal cancer. An analysis of 272 operated patients. Hepatogastroenterology 1996; 43(9):565-570.
77. Lygidakis NJ, Makuuchi M: Surgical anatomy of the liver in the presence of disease. Possibilities and expectations of perioperative ultrasonography. Hepatogastroenterology 1991; 38(4):321-328.
78. Makuuchi M, Takayama T, Kosuge T, et al: The value of ultrasonography for hepatic surgery. Hepatogastroenterology 1991; 38(1):64-70.
79. Torzilli G, Makuuchi M: Tricks for ultrasound-guided resection of colorectal liver metastases. Hepatogastroenterology 2003; 50(49):1-3.
80. Lygidakis NJ, Makuuchi M: Clinical application of peroperative ultrasonography in liver surgery. Hepatogastroenterology 1992; 39(3):232-236.
81. Minagawa M, Makuuchi M, Kubota K, Kondo Y: Intraoperative three-dimensional visualization of liver vasculature by ultrasonography. Hepatogastroenterology 2004; 51(59):1448-1450.
82. Yalcin S, Oyan B, Bayraktar Y: Current Medical Treatment of Pancreatic Neuroendocrine Tumors. Hepatogastroenterology 2007; 54:278-284.